Rapid Micro Biosystems, Inc. income statement

In fiscal 2025, Rapid Micro Biosystems, Inc. reported revenue of $33.6m, up 19.7% on the year before, operating income of −$47.4m (a -141.1% margin) and net income of −$47.1m, or −$1.05 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Rapid Micro Biosystems, Inc.: income statement, annual
Fiscal year	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Revenue	16	23	17	23	28	34	35
Research and development	7	10	13	13	15	14	13
Selling and marketing	6	12	15	13	13	12	13
General and administrative	10	18	27	25	22	23	25
Operating income	−31	−47	−63	−57	−50	−47	−50
Interest expense	3	3	—	—	0	1	2
Net interest income	—	−3	2	4	—	—	—
Income before tax	−37	−73	−61	−52	−47	−47	—
Income tax	0	0	−1	0	0	0	0
Net income	−37	−74	−61	−52	−47	−47	−51
Diluted EPS	−$126.11	−$3.94	−$1.43	−$1.22	−$1.08	−$1.05	−$1.11
Diluted shares (average)	—	20m	42m	43m	44m	45m	46m
EBITDA	−29	−46	−60	−53	−47	−44	−47

US$ millions unless shown otherwise. Fiscal quarters.

Rapid Micro Biosystems, Inc.: income statement, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Revenue	8	8	7	7	8	11	8	8
Cost of revenue	—	—	7	7	—	—	8	7
Gross profit	—	—	0	0	—	—	0	1
Research and development	4	3	4	3	4	3	3	3
Selling and marketing	3	3	3	3	3	3	3	3
General and administrative	6	5	6	6	6	5	7	7
Operating income	−12	−10	−12	−12	−11	−12	−14	−12
Interest expense	0	0	0	0	0	1	1	1
Income tax	0	−0	0	0	0	0	0	0
Net income	−11	−10	−11	−12	−12	−12	−14	−13
Diluted EPS	−$0.26	−$0.22	−$0.26	−$0.27	−$0.26	−$0.27	−$0.31	−$0.27
EBITDA	−11	−9	−11	−11	−11	−11	−13	−12

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: MXCT vs RPID OABI vs RPID BNGO vs RPID RPID vs TKNO

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Rapid Micro Biosystems, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Rapid Micro Biosystems, Inc.